President Donald Trump is expected to join NATO members during a summit this week in Ankara and confirm Washington’s commitment to Article 5 of the alliance’s mandate, which loosely means that an attack on one member is an attack on all.
Author: admin
Post
STUDY LINKS MICROPLASTICS IN ARTERIAL PLAQUE TO FOURFOLD INCREASE IN STROKE RISK
Right now, as you read this sentence, microscopic shards of plastic are likely lodged inside your brain tissue, your arteries, and the blood circulating to every organ in your body.
Post
THE UNFINISHED REVOLUTION: WHEN RIGHTS BECOME PRIVILEGES
What exactly are Americans celebrating this Fourth of July?
Post
OPENAI MAY GIVE U.S. GOVERNMENT 5-PERCENT OWNERSHIP
OpenAI and other AI labs are in discussions with U.S. officials about the government taking a 5-percent ownership stake in the companies.
Post
WHITE HOUSE, AI LABS NEGOTIATING STANDARDS FOR MODEL RELEASE
The Trump administration apparently has abandoned its hands-off approach to AI oversight and is in discussions with AI companies to create voluntary standards for the release of “frontier,” or leading-edge, models.
Post
BUSINESSES ARE SHOPPING FOR CHEAPER AI MODELS
As AI burst into the world less than four years ago, companies grabbed for large language models for fear of failing their investors and falling behind their competitors.
Post
U.N. WARNS OF CATASTROPHIC AI RISKS
Every four to seven months, AI models are doubling their ability to handle complex assignments, outpacing both government policies regulating them and their own designers’ understanding of them, according to a new assessment by the United Nations Independent International Scientific Panel on Artificial Intelligence.
Post
COMPANIES USING AI THE MOST ARE HIRING THE MOST, STUDY FINDS
So far, AI boosters’ claims that AI will create widespread jobs haven’t come true except, it seems, in companies that are making the most use of AI.
Post
DEMOCRATS PROBE INVESTMENTS LINKED TO TRUMP FAMILY
Democrats in the U.S. Senate are looking into investments related to the Trump family that would seem to profit from Donald Trump’s policy decisions.
Post
SPOTLIGHT: BIGS GETTING BIGGER
German pharma colossus Merck is paying $11.3 billion for Bio-Techne, a U.S. firm providing biochemicals, instruments, and other research tools to the biosciences industry.